Per Hellsund: Co-Founder and CEO of Cybrexa
Per Hellsund, co-founder and CEO of Cybrexa Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership, building a culture of transparency, and Cybrexa's advances in treating th...
25 Heinä 202036min
Clive Morris: CEO of Inivata
CEO Clive Morris of Inivata, headquartered in Cambridge U.K., shares his thoughts with BioBoss host John Simboli about leadership in biotech and advances in non-invasive liquid biopsy to unlock genomi...
11 Heinä 202041min
Samuel Murphy: Co-Founder of Salubris Biotherapeutics
Salubris Biotherapeutics Co-founder Samuel Murphy shares his thoughts about leadership in biopharma with BioBoss host John Simboli. Samuel also discusses Salubris Biotherapeutics advances in therapeu...
27 Kesä 202033min
Jason Meyenburg: CEO of Gemini Therapeutics
Gemini Therapeutics CEO Jason Meyenburg share his thoughts about leadership in biopharma with BioBoss host John Simboli. Jason also discusses Gemini Therapeutics pioneering approach to developing pre...
13 Kesä 202033min
Constantine Theodoropulos: Founder and CEO of Go Therapeutics
I'm not afraid of the gray area or the darkness that surrounds a few inches in front of your face, which is really what this business is all about." - Constantine Theodorpulos, Founder and CEO of Go T...
16 Touko 202041min
Ankit Mahadevia: CEO of Spero Therapeutics
"I really rely on the expertise of the team and I value input. I also value contradiction." - Ankit Mahadevia, founder and CEO of Spero Therapeutics
25 Huhti 202044min
Lewis Bender: Founder and CEO of Intensity Therapeutics
"It would have been a tremendous regret to have never tried—much worse than trying and failing. Much worse." - Lewis Bender, Founder and CEO of Intensity Therapeutics,
21 Maalis 202028min
Michel Detheux: CEO of iTeos Therapeutics
"I will always ask myself, what can I do with my knowledge in science to be able to bridge that to patients?" - Michel Detheux, co-founder and CEO of iTeos Therapeutics
17 Helmi 202035min
